EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Effectiveness of Leukocyte- and Platelet-rich Fibrin for Diabetic Foot Ulcers: A Retrospective Study

Fen Wang, Xiao-Ling Zhang, Jing Zhang, Song Gong, Jing Tao, Hui Xiang, Xiao-Qing Fu, Xu-Na Bian, Xue-Feng Yu, An-Hui Xu, Cheng-la Yi, Shi-Ying Shao

Current Medical Science · 2024

DOI: 10.1007/s11596-024-2874-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Medical Science, 2024. Verfasst von Fen Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Hauptthemen laut MEDLINE: Diabetic Foot, Platelet-Rich Fibrin, Wound Healing, Leukocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Diabetic foot ulcer (DFU) is one of the most serious complications of diabetes. Leukocyte- and platelet-rich fibrin (L-PRF) is a second-generation autologous platelet-rich plasma. This study aims to investigate the clinical effects of L-PRF in patients with diabetes in real clinical practice. METHODS: Patients with DFU who received L-PRF treatment and standard of care (SOC) from 2018 to 2019 in Tongji Hospital were enrolled. The clinical information including patient characteristics, wound evaluation (area, severity, infection, blood supply), SOC of DFU, and images of ulcers was retrospectively extracted and analyzed. L-PRF treatment was performed every 7±2 days until the ulcer exhibited complete epithelialization or an overall percent volume reduction (PVR) greater than 80%. Therapeutic effectiveness, including overall PVR and the overall and weekly healing rates, was evaluated. RESULTS: Totally, 26 patients with DFU were enrolled, and they had an ulcer duration of 47.0 (35.0, 72.3) days. The severity and infection of ulcers varied, as indicated by the Site, Ischemia, Neuropathy, Bacterial Infection, and Depth (SINBAD) scores of 2-6, Wagner grades of 1-4, and the Perfusion, Extent, Depth, Infection and Sensation (PEDIS) scores of 2-4. The initial ulcer volume before L-PRF treatment was 4.94 (1.50, 13.83) cm3, and the final ulcer volume was 0.35 (0.03, 1.76) cm3. The median number of L-PRF doses was 3 (2, 5). A total of 11 patients achieved complete epithelialization after the fifth week of treatment, and 19 patients achieved at least an 80% volume reduction after the seventh week. The overall wound-healing rate was 1.47 (0.63, 3.29) cm3/week, and the healing rate was faster in the first 2 weeks than in the remaining weeks. Concurrent treatment did not change the percentage of complete epithelialization or healing rate. CONCLUSION: Adding L-PRF to SOC significantly improved wound healing in patients with DFU independent of the ankle brachial index, SINBAD score, or Wagner grade, indicating that this method is appropriate for DFU treatment under different clinical conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootPlatelet-Rich FibrinWound HealingLeukocytesHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

autologous platelet-rich plasmadiabetic foot ulcerleukocyte- and platelet-rich fibrinpercentage volume reductionstandard of care

Autor:innen und Institutionen

  • Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, 430030, China.
  • Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Trauma Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. shaoshiyingtj@163.com.
  • Branch of National Clinical Research Center for Metabolic Diseases, Wuhan, 430030, China. shaoshiyingtj@163.com.

Zitieren

APA

Wang, F., Zhang, X. L., Zhang, J., Gong, S., Tao, J., Xiang, H., Fu, X. Q., Bian, X. N., Yu, X. F., Xu, A. H., Yi, C. L., & Shao, S. Y. (2024). Therapeutic Effectiveness of Leukocyte- and Platelet-rich Fibrin for Diabetic Foot Ulcers: A Retrospective Study. Current Medical Science. https://doi.org/10.1007/s11596-024-2874-2

Vancouver

Wang F, Zhang XL, Zhang J, Gong S, Tao J, Xiang H, et al. Therapeutic Effectiveness of Leukocyte- and Platelet-rich Fibrin for Diabetic Foot Ulcers: A Retrospective Study. Current Medical Science. 2024. doi:10.1007/s11596-024-2874-2

BibTeX
@article{Wang2024,
  author = {Wang, Fen and Zhang, Xiao-Ling and Zhang, Jing and Gong, Song and Tao, Jing and Xiang, Hui and Fu, Xiao-Qing and Bian, Xu-Na and Yu, Xue-Feng and Xu, An-Hui and Yi, Cheng-la and Shao, Shi-Ying},
  title = {Therapeutic Effectiveness of Leukocyte- and Platelet-rich Fibrin for Diabetic Foot Ulcers: A Retrospective Study},
  journal = {Current Medical Science},
  year = {2024},
  doi = {10.1007/s11596-024-2874-2}
}
Kostenlos starten →